Clinical Trial Update: The Effect Of Dual Treatment With L-Carnitine And Magnesium On Fatty Liver [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining the combined use of L-Carnitine and Magnesium for nonalcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• L-carnitine (L-carnitine)
• Magnesium (magnesium)

Snippet

Sponsor: Meir Medical Center | Conditions: Non Alcoholic Fatty Liver Disease | Phase 4 | Status: UNKNOWN